| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/16/2004 | WO2004108134A1 Medicinal composition containing triazole compound |
| 12/16/2004 | WO2004108133A2 Modulators of vr1 receptor |
| 12/16/2004 | WO2004108131A1 Compounds inhibiting the binding of sap for treating osteoarthritis |
| 12/16/2004 | WO2004108130A1 Methods and compounds for the treatment of vascular stenosis |
| 12/16/2004 | WO2004108129A1 Stem cell invasion inhibitor |
| 12/16/2004 | WO2004108128A1 The use of bullatacin in manufacturing the medicaments of suppressing aids virus |
| 12/16/2004 | WO2004108127A1 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 12/16/2004 | WO2004108126A1 Fibric acid derivatives for the treatment of irritable bowel syndrome |
| 12/16/2004 | WO2004108125A1 Coronavirus inactivating agent |
| 12/16/2004 | WO2004108124A1 Natural semi-synthetic and synthetic lipid derivatives of ceramide and sphingosine groups, drugs and the medical use thereof in the form of therapeutic agents in particular for dermatology |
| 12/16/2004 | WO2004108123A1 Preventive and/or remedy for kidney diseases |
| 12/16/2004 | WO2004108122A1 Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (sars) |
| 12/16/2004 | WO2004108121A1 Use of hif alpha stabilizers for enhancing erythropoiesis |
| 12/16/2004 | WO2004108120A1 Use of growth hormone secretagogues for treatment of fibromyalgia |
| 12/16/2004 | WO2004108119A2 Use of atp or derivatives in medicine |
| 12/16/2004 | WO2004108115A1 Process for producing microparticle |
| 12/16/2004 | WO2004108114A2 Anti-fungal composition and a process for its manufacture |
| 12/16/2004 | WO2004108113A1 Improved novel, clear, painless preparation of propofol |
| 12/16/2004 | WO2004108112A1 Pressure-sensitive adhesive composition for preparation for external use on skin and pressure-sensitive adhesive sheet preparation for external use on skin |
| 12/16/2004 | WO2004108110A1 Sublingual administration of non-steroidal anti-inflammatory pharmacological substances |
| 12/16/2004 | WO2004108109A1 Method for producing a solid pharmaceutical composition |
| 12/16/2004 | WO2004108103A1 Oral cereal beta glucan compositions |
| 12/16/2004 | WO2004108094A2 Sulfonamide-substituted chalcone derivatives and their use to treat diseases |
| 12/16/2004 | WO2004108093A2 Antiseptic compositions, methods and systems |
| 12/16/2004 | WO2004108092A2 Tannate compositions and methods of use |
| 12/16/2004 | WO2004108091A2 Antimicrobial flush solutions |
| 12/16/2004 | WO2004108086A2 HYDANTOIN DERIVATIVES AS INHIBITORS OF TUMOR NECROSIS FACTOR-α CONVERTING ENZYME (TACE) |
| 12/16/2004 | WO2004108085A2 Methods for the protection of memory and cognition |
| 12/16/2004 | WO2004108084A2 Polymorphic forms of naltrexone |
| 12/16/2004 | WO2004108083A2 Methods for the selective treatment of tumors by calcium-mediated induction of apoptosis |
| 12/16/2004 | WO2004108080A2 Method for treating diseases using hsp90-inhibiting agents in combination with immunosuppressants |
| 12/16/2004 | WO2004108077A2 Method of mitigating the adverse effects of il-2 |
| 12/16/2004 | WO2004108076A2 Anti-hiv benzamide compounds |
| 12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | WO2004108064A2 Diosgenin-based composition suitable for topical application |
| 12/16/2004 | WO2004108062A2 Prophylaxis and/or treatment of portal hypertension |
| 12/16/2004 | WO2004108061A2 Stable injectable pharmaceutical composition of thiopental; method for stabilizing aqueous solutions of thiopental and, use of thiopental for producing a medicament |
| 12/16/2004 | WO2004107958A2 Sterol markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
| 12/16/2004 | WO2004107881A1 Nutritional compositions and use thereof |
| 12/16/2004 | WO2004096224A3 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 12/16/2004 | WO2004093883A3 Sachet for a pharmaceutical composition |
| 12/16/2004 | WO2004091541A3 Methods for the controlled delivery of pharmacologically active compounds |
| 12/16/2004 | WO2004091474A3 Methods for the preparation of dhea derivatives |
| 12/16/2004 | WO2004089414A3 Combinations of proton pump inhibitors or blockers with prokinetic agents |
| 12/16/2004 | WO2004089353A3 Methods for treatment of parkinson's disease |
| 12/16/2004 | WO2004089352A3 Pharmaceutical combination for the treatment of spasticity and/or pain |
| 12/16/2004 | WO2004089329A3 Topical compositions comprising n-acetylamino acids or related n-acetyl compounds |
| 12/16/2004 | WO2004089311A3 Polymeric drug agents for the treatment of fibrotic disorders |
| 12/16/2004 | WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions |
| 12/16/2004 | WO2004087651A3 Formulations for tyrosine kinase inhibitors |
| 12/16/2004 | WO2004087212A3 Nitric oxide in treatment of inflammation |
| 12/16/2004 | WO2004087211A3 Inhibitors of phosphodiesterases in infertility |
| 12/16/2004 | WO2004087116A3 Drug combination for motor dysfunction in parkinson's disease |
| 12/16/2004 | WO2004087043A3 Stable ophthalmic formulation containing an antibiotic and a corticosteroid |
| 12/16/2004 | WO2004082590A3 A low dose corticosteroid composition |
| 12/16/2004 | WO2004080448A3 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 12/16/2004 | WO2004080444B1 Methods for treating lower urinary tract disorders and the related disorders vulvodynia and vulvar vestibulitis using cav2.2 subunit calcium channel modulators |
| 12/16/2004 | WO2004080411A3 Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto |
| 12/16/2004 | WO2004078940A3 USE OF ANTISENSE OLIGONUCLEOTIDES OR siRNA TO SUPPRESS EXPRESSION OF eIF-5A1 |
| 12/16/2004 | WO2004078136A3 Pyridinium salts, compounds and methods of use |
| 12/16/2004 | WO2004074309A8 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 12/16/2004 | WO2004073602A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders |
| 12/16/2004 | WO2004072029A3 Pyrazolopyridazines useful as inhibitors of protein kinases |
| 12/16/2004 | WO2004066930A3 Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives |
| 12/16/2004 | WO2004066929A3 Cycloalkyl containing anilide ligands for the thyroid receptor |
| 12/16/2004 | WO2004064832A3 Methods for treating joint pain or improving sleep using an estrogen agonist/antagonist |
| 12/16/2004 | WO2004064735A3 Treatment of benign prostatic hyperplasia |
| 12/16/2004 | WO2004064728A3 Use of specific tetracycline compounds in therapy |
| 12/16/2004 | WO2004058140B1 Non-pegylated long-circulating liposomes |
| 12/16/2004 | WO2004056374A8 Use of glycyrrhizin for the treatment of standard therapy-resistant hepatitis c patients |
| 12/16/2004 | WO2004052299A3 Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid |
| 12/16/2004 | WO2004050022A8 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/16/2004 | WO2004047737A3 Nucleotide based medicament and method of use for treatment of conditions in humans |
| 12/16/2004 | WO2004027047A3 INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE AND USES THEREFOR |
| 12/16/2004 | WO2004026293A3 Hemiasterlin derivatives for treating resistant tumors |
| 12/16/2004 | WO2004023889A3 Full range nutritional supplements from plant materials and methods for their manufacture |
| 12/16/2004 | WO2004006848A3 Combination therapies with ftc for the treatment of hepatitis b virus infection |
| 12/16/2004 | WO2003090684A8 Polymer compositions containing a macrocyclic triene compound |
| 12/16/2004 | WO2003071922A3 Use of modulators of nicotinic receptors for treatment of cognitive dysfunction |
| 12/16/2004 | WO2003027254A3 15625 receptor, a novel g-protein coupled receptor |
| 12/16/2004 | US20040254383 Reacting a dipyrromethane with an oxidant and a metal salt to produce the bis(dipyrrinato)metal complex; for making molecular memory devices, solar cells and light harvesting arrays |
| 12/16/2004 | US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 12/16/2004 | US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory |
| 12/16/2004 | US20040254376 Cyclic amidine derivative |
| 12/16/2004 | US20040254375 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 12/16/2004 | US20040254374 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases |
| 12/16/2004 | US20040254371 New benzothiazine and benzothiadiazine compounds |
| 12/16/2004 | US20040254370 Peroxisome proliferators activated receptor regulator; useful for hypoglycemia, hypolipidemia, preventing and/or treatment of diseases associating metabolic disorders, atherosclerosis, cardiovascular diseases, syndrome x, cholestrol |
| 12/16/2004 | US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 12/16/2004 | US20040254252 Tpoical applying a mixture containing alkoxybenzaldehyde compound |
| 12/16/2004 | US20040254251 Controlling dosage; prepackages |
| 12/16/2004 | US20040254250 Control of protozoa and protozoan cysts that harbor Legionella |
| 12/16/2004 | US20040254249 Nonsteroidal antiinflammatory agents |
| 12/16/2004 | US20040254248 In mouth, mucous membranes; using citric acid salt or succinic acid salt as wound healing agents |
| 12/16/2004 | US20040254247 Method and composition for treatnment of ocular hypertension and glaucoma |
| 12/16/2004 | US20040254246 Treating or preventing hot flashes using prodrugs of GABA analogs |
| 12/16/2004 | US20040254245 Using extract of olive leaves; moisturizers; antiinflammatory agents; prevention of acne |
| 12/16/2004 | US20040254244 Agent for prophylaxis or treatment of inflammatory bowel diseases |
| 12/16/2004 | US20040254243 Drink preparation comprising ketoprofen and its use in the simultaneous treatment of conditions causing fever, inflammation and pain in a herd of animals |
| 12/16/2004 | US20040254240 Anti-cancer nitro- and thia-fatty acids |